Navigation Links
Aderans Research BIO International Press Release
Date:5/31/2009

ARI a Key Presence at Recent BIO International Convention

Atlanta, GA (PRWEB) May 31, 2009 -- Aderans Research Institute Inc. (ARI) was a notable presence at the recent BIO International Convention. The leading hair regeneration company joined more than 1,800 companies from 58 countries around the globe at the world's largest annual event for the biotechnology industry, held May 18-21 at the Georgia World Congress Center.

Co-located in Atlanta and Philadelphia, ARI is actively engaged in the study of state-of-the-art cell-based hair regeneration for men and women. The company recently launched Phase 2 of its clinical study to assess the impact of its regenerative cell treatment on pattern hair loss, also known as androgenetic alopecia. Phase 2 of the study is being conducted in six U.S. cities: Atlanta, Boston, New York, Raleigh, Houston, and Washington DC. Phase 1 was conducted exclusively in the United Kingdom.

"Our research is focused on generating a tissue engineering solution to the regeneration of hair," said Kurt Stenn, MD, Vice President and Chief Scientific Officer at ARI. "We're using the hair cells from hair follicles and researching methods to promote their growth in controlled laboratory environments. If successful, we'll then be able to recombine the cells and restore them to the scalp, where they would ultimately elicit hair growth."

A dynamic field on the cutting-edge of the hair restoration industry, cell treatment represents a major advance on traditional hair transplant procedures, promising to overcome a key limitation of conventional transplantation: a finite hair supply for any one person. Through leading edge cell engineering, Aderans Research is pioneering efforts to multiply existing hair cells capable of eliciting hair growth, providing patients with a comprehensive solution to hair loss regardless of the quantity of their existing hair.

About the BIO International Convention:
The BIO International Convention is the largest global event for the biotechnology industry, offering key networking and partnering opportunities, and providing insight on major trends affecting the industry. The convention is produced by BIO, the world's largest biotechnology organization, representing more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and abroad. BIO works to create a favorable policy environment for biotechnological innovation. Its members are involved in marketing, research and development across the healthcare, agriculture, industrial and environmental biotechnology fields.

Learn more at: http://convention.bio.org/

About Aderans Research:
Aderans Research is dedicated to solving the pervasive problem of hair loss and becoming the world leader in the research and development of safe, effective cell engineered products for hair regeneration.

With offices in Atlanta and Philadelphia, Aderans Research Institute is a subsidiary of Aderans Company, Ltd, the world's largest wig manufacturer, and an affiliate of Bosley, a global leader in medical hair restoration.

More information on ARI's study outcomes will be released as studies conclude. To see ARI's latest clinical updates, please visit http://aderansresearch.com/ari_clinicalupdates.html

Additional information on ARI can be found at www.aderansresearch.com.

Contact:
Vern Liebmann
Tel: 678.213.1913

###

Read the full story at http://www.prweb.com/releases/hair/regeneration/prweb2478234.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Aderans Research Launches Second Phase of Hair Loss Study
2. Pitt melanoma researchers present novel findings at ASCO
3. Indiana U. research at the American College of Sports Medicine conference
4. UTSA Dean George Perry co-edits textbook chronicling four decades of Alzheimers research
5. Researchers develop light-treatment device to improve sleep quality in the elderly
6. Cancer research partnership between UCSF, MMRF to drive drug development
7. AGA Institute presents cutting-edge research during DDW
8. MU researchers offer insights for advancing health communication through digital media
9. Raymond Tye Named Trustee at Schepens Eye Research Institute
10. 5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment
11. LSUHSC dental researcher funded to develop better dental materials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aderans Research BIO International Press Release
(Date:5/29/2016)... (PRWEB) , ... May 29, 2016 , ... Whole Health ... Amazon.com, their new KlipPro KP-240L clipper is available to the public. This is an ... is substantially wider than the average clipper. , Everything about this product is concentrated ...
(Date:5/28/2016)... ... May 28, 2016 , ... After a year and a half of planning the ... extraordinary event. The Multiple Pathways of Recovery Conference was held May 2 -4, 2016 ... and the United Kingdom came together to explore the many pathways individuals use to get ...
(Date:5/27/2016)... ... , ... W.S. Badger Co. Inc ., the maker of certified organic ... one of the best small businesses for new dads by Fatherly, the digital lifestyle ... providing progressive benefits to new parents on the organization’s 2016 Best Places to ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... ... With a team of certified experts, Validation Center is ... GMP accreditation, Validation Center is also a registered authority of the international system ... Validation Center is ISO17025 accredited and only offers its clients the latest technology, ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 LabStyle ... Dario™ Diabetes Management Tool, today announced that the Company,s Chief ... Marcum MicroCap Conference being held June 1-2 in ... being held June 7-9 in Los Angeles, CA. ... discuss recent corporate and operational milestones, including the U.S. FDA ...
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... 2016 According to a new market ... - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast ... U.S. was valued at US$ 5.89 Bn in 2014 and ... 2015 to 2023 to reach US$ 7.99 Bn in 2023. ... emerging needle free drug delivery devices and the market is ...
Breaking Medicine Technology: